# Targeted analysis of whole exome sequencing in Thai patients with neonatal diabetes

**Authors:** Nattachet Plengvidhya, Thanida Tangjarusritaratorn, Nipaporn Teerawattanapong, Tassanee Narkdontri, Saranya Innang, Suavaluk Songlilitchuwong, Sarocha Suthon, Watip Tangjittipokin

PMC · DOI: 10.1007/s00439-025-02815-0 · 2026-01-07

## TL;DR

This study identifies genetic causes of neonatal diabetes in Thai patients using whole exome sequencing, revealing new insights into the condition's genetic diversity in this population.

## Contribution

The first genetic analysis of neonatal diabetes in Thai patients, highlighting novel pathogenic variants and successful precision therapy outcomes.

## Key findings

- Eight out of 14 Thai NDM patients had variants in established NDM genes like KCNJ11, ABCC8, and INS.
- Two patients with KCNJ11 variants achieved excellent glycemic control using sulfonylureas.
- Six patients had pathogenic variants in genes linked to monogenic diabetes, including LRBA, EIF2AK3, and WFS1.

## Abstract

Neonatal diabetes mellitus (NDM) typically presents within the first 6 months of life and generally lacks islet autoantibodies. Genetic elucidation of NDM is a prime example of precision medicine in diabetes. However, no published genetic data exist for NDM in Thailand. We aimed to assess the genetic etiology of Thai NDM using whole exome sequencing (WES). We enrolled 14 Thai patients with NDM and measured GAD65, IA-2, and ZnT8 autoantibodies. We then performed WES and analyzed 43 NDM-related genes to identify causative variants. All subjects tested negative for the three islet autoantibodies. Eight harbored variants in well-established NDM genes (KCNJ11 [n = 5], ABCC8 [n = 1], INS [n = 2 in identical twins]). Two patients with KCNJ11 variants (rs80356616: p.Val59Met and rs8035661: p.Arg50Gln) achieved excellent glycemic control on sulfonylureas, illustrating precision therapy. The remaining six carried pathogenic variants in genes associated with monogenic diabetes, including LRBA, EIF2AK3, DOCK8, WFS1, GATA6, CISD2/SLC9B1, and COQ2. This is the first report on the genetic etiology of NDM in Thailand. WES is an effective approach to identifying variants in this rare diabetes subtype. Larger cohort studies are needed to determine the true prevalence of NDM in Thailand.

The online version contains supplementary material available at 10.1007/s00439-025-02815-0.

## Linked entities

- **Genes:** KCNJ11 (potassium inwardly rectifying channel subfamily J member 11) [NCBI Gene 3767], ABCC8 (ATP binding cassette subfamily C member 8) [NCBI Gene 6833], INS (insulin) [NCBI Gene 3630], LRBA (LPS responsive beige-like anchor protein) [NCBI Gene 987], EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451], DOCK8 (dedicator of cytokinesis 8) [NCBI Gene 81704], WFS1 (wolframin ER transmembrane glycoprotein) [NCBI Gene 7466], GATA6 (GATA binding protein 6) [NCBI Gene 2627], CISD2 (CDGSH iron sulfur domain 2) [NCBI Gene 493856], SLC9B1 (solute carrier family 9 member B1) [NCBI Gene 150159], COQ2 (coenzyme Q2, polyprenyltransferase) [NCBI Gene 27235]
- **Proteins:** GAD2 (glutamate decarboxylase 2), PTPRN (protein tyrosine phosphatase receptor type N), SLC30A10 (solute carrier family 30 member 10)
- **Diseases:** neonatal diabetes mellitus (MONDO:0016391), NDM (MONDO:0016391)

## Full-text entities

- **Genes:** SLC9B1 (solute carrier family 9 member B1) [NCBI Gene 150159] {aka NHA1, NHEDC1}, COQ2 (coenzyme Q2, polyprenyltransferase) [NCBI Gene 27235] {aka CL640, COQ10D1, MSA1, PHB:PPT}, WFS1 (wolframin ER transmembrane glycoprotein) [NCBI Gene 7466] {aka CTRCT41, WFRS, WFS, WFSL}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, SLC30A8 (solute carrier family 30 member 8) [NCBI Gene 169026] {aka ZNT8, ZnT-8}, PTPRN (protein tyrosine phosphatase receptor type N) [NCBI Gene 5798] {aka IA-2, IA-2/PTP, IA2, ICA512, R-PTP-N}, GATA6 (GATA binding protein 6) [NCBI Gene 2627], ABCC8 (ATP binding cassette subfamily C member 8) [NCBI Gene 6833] {aka ABC36, HHF1, HI, HRINS, MODY12, MRP8}, GAD2 (glutamate decarboxylase 2) [NCBI Gene 2572] {aka GAD65}, CISD2 (CDGSH iron sulfur domain 2) [NCBI Gene 493856] {aka ERIS, Miner1, NAF-1, WFS2, ZCD2}, LRBA (LPS responsive beige-like anchor protein) [NCBI Gene 987] {aka BGL, CDC4L, CVID8, LAB300, LBA, uc.147}, KCNJ11 (potassium inwardly rectifying channel subfamily J member 11) [NCBI Gene 3767] {aka BIR, HHF2, IKATP, KIR6.2, MODY13, PHHI}, DOCK8 (dedicator of cytokinesis 8) [NCBI Gene 81704] {aka HEL-205, HIES2, MRD2, ZIR8}
- **Diseases:** neonatal diabetes (MESH:C563322), NDM (MESH:D003920)
- **Chemicals:** sulfonylureas (MESH:D013453)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs8035661, p.Val59Met, p.Arg50Gln

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12779698/full.md

---
Source: https://tomesphere.com/paper/PMC12779698